Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $46.8200 (-2.13%) ($46.7900 - $48.0200) on Fri. Nov. 11, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.25% (three month average) | RSI | 42 | Latest Price | $46.8200(-2.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -0.1% a day on average for past five trading days. | Weekly Trend | BAX declines -0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(52%) VYM(51%) SPY(49%) IVE(48%) | Factors Impacting BAX price | BAX will decline at least -0.625% in a week (0% probabilities). TLT(-17%) VIXM(-16%) GDXJ(-9%) UUP(-5%) TIP(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.625% (StdDev 1.25%) | Hourly BBV | 0 () | Intraday Trend | -2% | | | |
|
Resistance Level | $47.52 | 5 Day Moving Average | $47.39(-1.2%) | 10 Day Moving Average | $47.21(-0.83%) | 20 Day Moving Average | $47.52(-1.47%) | To recent high | -4.8% | To recent low | 3.8% | Market Cap | $23.887b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |